{"id":5475,"date":"2026-01-15T10:00:01","date_gmt":"2026-01-15T07:00:01","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=5475"},"modified":"2026-01-15T10:00:03","modified_gmt":"2026-01-15T07:00:03","slug":"agamree-vamorolone-has-been-approved-in-switzerland-by-swissmedic","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/tr\/agamree-vamorolone-has-been-approved-in-switzerland-by-swissmedic\/","title":{"rendered":"AGAMREE (Vamorolone), \u0130svi\u00e7re'de Swissmedic Taraf\u0131ndan Onayland\u0131"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Santhera Pharmaceuticals, \u0130svi\u00e7re Terap\u00f6tik \u00dcr\u00fcnler Ajans\u0131&#039;n\u0131n (Swissmedic), AGAMREE (vamorolone) ilac\u0131n\u0131 d\u00f6rt ya\u015f ve \u00fczeri hastalarda Duchenne kas distrofisi (DMD) tedavisi i\u00e7in onaylad\u0131\u011f\u0131n\u0131 duyurdu. <strong>Daha fazla bilgi edin:<\/strong> <a href=\"https:\/\/dmdwarrior.com\/tr\/what-is-agamree-vamorolone-what-is-agamree-used-for\/\" target=\"_blank\" data-type=\"post\" data-id=\"2333\" rel=\"noreferrer noopener\">AGAMREE (Vamorolone) nedir?<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Santhera&#039;n\u0131n CEO&#039;su Dario Eklund \u015fu yorumda bulundu: &quot;Gururla \u0130svi\u00e7re merkezli bir \u015firket olarak, Swissmedic onay\u0131n\u0131 almak \u00f6nemli bir ba\u015far\u0131y\u0131 temsil ediyor ve k\u00fcresel pazarlama onaylar\u0131m\u0131z\u0131n yedincisini olu\u015fturuyor.&quot;. <strong>DMD hastalar\u0131n\u0131n bu \u00f6nemli tedaviye zaman\u0131nda eri\u015fimini sa\u011flamak amac\u0131yla, AGAMREE&#039;yi 2026 y\u0131l\u0131n\u0131n sonlar\u0131na do\u011fru \u0130svi\u00e7re&#039;de piyasaya s\u00fcrmeyi hedefliyoruz.<\/strong>\u201d<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Swissmedic&#039;in AGAMREE&#039;ye verdi\u011fi onay, kritik \u00f6neme sahip Faz 2b VISION-DMD \u00e7al\u0131\u015fmas\u0131ndan elde edilen verilere ve Avrupa \u0130la\u00e7 Ajans\u0131&#039;n\u0131n de\u011ferlendirme sonu\u00e7lar\u0131na dayanmaktad\u0131r. <strong>Onay sonras\u0131nda, \u015eirkete \u0130svi\u00e7re yetim ila\u00e7 stat\u00fcs\u00fc kapsam\u0131nda 15 y\u0131ll\u0131k m\u00fcnhas\u0131rl\u0131k s\u00fcresi tan\u0131nm\u0131\u015ft\u0131r.<\/strong> Santhera, AGAMREE&#039;nin \u0130svi\u00e7re&#039;deki m\u00fcnhas\u0131r da\u011f\u0131t\u0131m haklar\u0131n\u0131 elinde bulundurmaktad\u0131r ve ulusal fiyatland\u0131rma ve geri \u00f6deme prosed\u00fcrlerinin tamamlanmas\u0131n\u0131n ard\u0131ndan 2026 y\u0131l\u0131n\u0131n ikinci yar\u0131s\u0131nda ticari lansman yapmay\u0131 \u00f6ng\u00f6rmektedir. <strong>\u0130svi\u00e7re&#039;de DMD hastal\u0131\u011f\u0131ndan etkilenen 200&#039;den fazla insan var ve onlara sunulan tedavi se\u00e7enekleri olduk\u00e7a s\u0131n\u0131rl\u0131.<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Devam\u0131n\u0131 oku<\/strong>:&nbsp;<a href=\"https:\/\/dmdwarrior.com\/tr\/dmd-therapies\/\" target=\"_blank\" rel=\"noreferrer noopener\">Duchenne \u0130\u00e7in Klinik Ara\u015ft\u0131rmalar (T\u00fcm Ara\u015ft\u0131rmalar\u0131n Listesi)<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Santhera Pharmaceuticals announces that the Swiss Agency for Therapeutic Products (Swissmedic), has approved AGAMREE (vamorolone) for the treatment of Duchenne muscular dystrophy (DMD) in patients four years of age and older. Learn More: What is AGAMREE (Vamorolone)? Dario Eklund, Chief Executive Officer of Santhera, commented: \u201cAs a proudly Switzerland-based business, securing Swissmedic approval represents an [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":5477,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[281],"tags":[42,41,477,476,43],"class_list":["post-5475","post","type-post","status-publish","format-standard","has-post-thumbnail","category-press-releases","tag-agamree","tag-santhera","tag-swissmedic","tag-switzerland","tag-vamorolone"],"subtitle":"AGAMREE (Vamorolone)'nin 2026 y\u0131l\u0131n\u0131n sonlar\u0131nda \u0130svi\u00e7re'de piyasaya s\u00fcr\u00fclmesi bekleniyor.","_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts\/5475","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/comments?post=5475"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts\/5475\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/media\/5477"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/media?parent=5475"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/categories?post=5475"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/tags?post=5475"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}